Fight-302: Phase 3 Study Of First-Line Pemigatinib Vs Gemcitabine Plus Cisplatin For Cholangiocarcinoma With Fgfr2 Fusions Or Rearrangement
ONCOLOGY RESEARCH AND TREATMENT(2021)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
ONCOLOGY RESEARCH AND TREATMENT(2021)